Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab

Submitted: 9 November 2011
Accepted: 9 November 2011
Published: 9 November 2011
Abstract Views: 943
PDF: 723
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We present a rare case of splenic tuberculosis in a 42-year old man with long-standing ankylosing spondylitis treated with adalimumab. We review the association between antitumor necrosis factor therapy and splenic tuberculosis. Our case, like many other reported cases, illustrates that the index of suspicion of tuberculosis in patients treated with anti TNF therapies must be high and emphasizes that this rare infection may occur even with negative tuberculosis screening before the initiation of therapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Azevedo, V., Paiva, E., Tosin, T., Ferreira, A., Ferreira, A., & Fernandes, M. (2011). Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab. Reumatismo, 63(3), 171–174. https://doi.org/10.4081/reumatismo.2011.171

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.